Plain-English translation of NCT07121504 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Type 2 Diabetes research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study compares two types of insulin pumps for people with type 2 diabetes who are having surgery and receiving nutrition through an IV during recovery. One group will use a hybrid closed-loop insulin delivery system—a 'smart' pump that automatically adjusts insulin based on your blood sugar readings. The other group will use a standard insulin pump that requires manual adjustments. The trial wants to see which approach keeps blood sugar better controlled during this critical hospital period.
After surgery, people with diabetes often struggle to keep their blood sugar stable, especially when receiving IV nutrition. The new treatment may automatically respond to blood sugar changes better than standard pumps, potentially reducing complications and speeding recovery.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will be randomly assigned to receive either the smart insulin pump or the standard pump during your hospital stay after surgery. You will be monitored for 5 to 7 days while the pump manages your insulin delivery and your medical team tracks your blood sugar control. You will need to allow the pump to be attached to your body and follow your care team's instructions for the treatment period.
AI-generated summary from trial data · Jun 28, 2026 · Not medical advice
China